News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
CeNes Pharmaceuticals (U.S.) Gets Takeover Approach
February 5, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON (Reuters) - Shares in CeNeS Pharmaceuticals surged on Tuesday after the firm said it was in talks that may lead to an offer for the company.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Mergers & acquisitions
After Missing Kezar Buyout in 2024, Tang Returns as CEO of Aurinia With $50M Offer
March 30, 2026
·
2 min read
·
Annalee Armstrong
Deals
Lilly Doubles Down on Insilico’s AI Medicines, Bets up to $2.75B
March 30, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Novartis Keeps Deals Coming With $2B Excellergy Takeover
March 27, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms
March 25, 2026
·
3 min read
·
Tristan Manalac
